Key Takeaways Mazdutide is approved in China for weight management and type 2 diabetes but not yet available in the UK Mazdutide targets GLP-1 and glucagon, while semaglutide targets GLP-1 only One head-to-head trial showed greater weight loss with mazdutide (10.29% vs 6%) Both are once-weekly injections with similar mild digestive side effects Semaglutide is available in the UK now
Monitor patients to minimize loss of lean body mass
If sugar cravings coincide with symptoms such as trembling, sweating, confusion, or palpitations, blood glucose should be checked immediately
Our testing process is part of a larger quality-control system that includes supplier accountability, batch-level review, internal QA, professional storage, and in-house fulfillment
doi: 10.1021/acs.jmedchem.5b00726 Jensen L, Helleberg H, Roffel A, et al